SOUTH SAN FRANCISCO, Calif., December 10, 2024--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback